Aerovate Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Aerovate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aerovate Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aerovate Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $885k | 353k | 2.51 |
| 2024-12-31 | $833k | 314k | 2.65 |
| 2024-09-30 | $337k | 161k | 2.09 |
| 2024-06-30 | $151k | 91k | 1.66 |
| 2021-12-31 | $221k | 19k | 11.78 |